Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma

Karolin Heinze, Tayyebeh M. Nazeran, Sandra Lee, Pauline Krämer, Evan S. Cairns, Derek S. Chiu, Samuel C.Y. Leung, Eun Young Kang, Nicola S. Meagher, Catherine J. Kennedy, Jessica Boros, Friedrich Kommoss, Hans-Walter Vollert, Florian Heitze, Andreas du Bois, Philipp Harter, Marcel Grube, Bernhard Kraemer, Annette Staebler, Felix K.F. Kommoss, Sabine Heublein, Hans-Peter Sinn, Naveena Singh, Angela Laslavic, Esther Elishaev, Alex Olawaiye, Kirsten Moysich, Francesmary Modugno, Raghwa Sharma, Alison H. Brand, Paul R. Harnett, Anna DeFazio, Renée T. Fortner, Jan Lubinski, Marcin Lener, Aleksandra Tołoczko-Grabarek, Cezary Cybulski, Helena Gronwald, Jacek Gronwald, Penny Coulson, Mona A El-Bahrawy, Michael E. Jones, Minouk J. Schoemaker, Anthony J. Swerdlow, Kylie L. Gorringe, Ian Campbell, Linda Cook, Simon A. Gayther, Michael E. Carney, Yurii B. Shvetsov, Brenda Y. Hernandez, Lynne R. Wilkens, Marc T. Goodman, Constantina Mateoiu, Anna Linder, Karin Sundfeldt, Linda E. Kelemen, Aleksandra Gentry-Maharaj, Martin Widschwendter, Usha Menon, Kelly L. Bolton, Jennifer Alsop, Mitul Shah, Mercedes Jimenez-Linan, Paul D.P. Pharoah, James D. Brenton, Kara L. Cushing-Haugen, Holly R. Harris, Jennifer A. Doherty, Blake Gilks, Prafull Ghatage, David G. Huntsman, Gregg S. Nelson, Anna V. Tinker, Cheng-Han Lee, Ellen L. Goode, Brad H. Nelson, Susan J. Ramus, Stefan Kommoss, Aline Talhouk, Martin Köbel, Michael S. Anglesio
doi: https://doi.org/10.1101/2021.09.16.21262993

Article Information

doi 
https://doi.org/10.1101/2021.09.16.21262993
History 
  • September 21, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Karolin Heinze*,1,2,
  2. Tayyebeh M. Nazeran*,2,
  3. Sandra Lee3,
  4. Pauline Krämer1,4,
  5. Evan S. Cairns1,
  6. Derek S. Chiu2,
  7. Samuel C.Y. Leung2,
  8. Eun Young Kang3,
  9. Nicola S. Meagher5,6,
  10. Catherine J. Kennedy7,8,
  11. Jessica Boros7,8,
  12. Friedrich Kommoss9,
  13. Hans-Walter Vollert10,
  14. Florian Heitze11,
  15. Andreas du Bois11,
  16. Philipp Harter11,
  17. Marcel Grube1,4,
  18. Bernhard Kraemer4,
  19. Annette Staebler12,
  20. Felix K.F. Kommoss13,
  21. Sabine Heublein14,
  22. Hans-Peter Sinn13,
  23. Naveena Singh15,
  24. Angela Laslavic16,
  25. Esther Elishaev17,
  26. Alex Olawaiye16,
  27. Kirsten Moysich18,
  28. Francesmary Modugno16,
  29. Raghwa Sharma19,20,21,
  30. Alison H. Brand8,20,
  31. Paul R. Harnett8,22,
  32. Anna DeFazio7,8,20,23,
  33. Renée T. Fortner24,
  34. Jan Lubinski25,
  35. Marcin Lener25,
  36. Aleksandra Tołoczko-Grabarek25,
  37. Cezary Cybulski25,
  38. Helena Gronwald26,
  39. Jacek Gronwald25,
  40. Penny Coulson27,
  41. Mona A El-Bahrawy28,
  42. Michael E. Jones27,
  43. Minouk J. Schoemaker27,
  44. Anthony J. Swerdlow27,29,
  45. Kylie L. Gorringe30,31,
  46. Ian Campbell30,32,
  47. Linda Cook33,
  48. Simon A. Gayther34,
  49. Michael E. Carney35,
  50. Yurii B. Shvetsov36,
  51. Brenda Y. Hernandez36,
  52. Lynne R. Wilkens36,
  53. Marc T. Goodman37,
  54. Constantina Mateoiu38,
  55. Anna Linder38,
  56. Karin Sundfeldt38,
  57. Linda E. Kelemen39,
  58. Aleksandra Gentry-Maharaj40,41,
  59. Martin Widschwendter42,
  60. Usha Menon40,
  61. Kelly L. Bolton43,
  62. Jennifer Alsop44,
  63. Mitul Shah45,
  64. Mercedes Jimenez-Linan45,
  65. Paul D.P. Pharoah44,46,
  66. James D. Brenton47,
  67. Kara L. Cushing-Haugen48,
  68. Holly R. Harris48,
  69. Jennifer A. Doherty49,
  70. Blake Gilks2,
  71. Prafull Ghatage50,
  72. David G. Huntsman1,2,
  73. Gregg S. Nelson50,
  74. Anna V. Tinker2,51,
  75. Cheng-Han Lee52,
  76. Ellen L. Goode53,
  77. Brad H. Nelson54,
  78. Susan J. Ramus5,6,
  79. Stefan Kommoss4,
  80. Aline Talhouk1,2,
  81. Martin Köbel□,3 and
  82. Michael S. Anglesio□,1,2
  1. 1University of British Columbia, Department of Obstetrics and Gynecology, Vancouver, BC, Canada
  2. 2University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia’s Gynecological Cancer Research Team (OVCARE), Vancouver, BC, Canada
  3. 3University of Calgary, Department of Pathology and Laboratory Medicine, Calgary, AB, Canada
  4. 4University Hospital Tübingen, Department of Women’s Health, Tübingen, Germany
  5. 5University of New South Wales, Adult Cancer Program, Lowy Cancer Research Centre, Sydney, New South Wales, Australia
  6. 6University of New South Wales, School of Women’s and Children’s Health, Sydney, New South Wales, Australia
  7. 7The University of Sydney, Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia
  8. 8Westmead Hospital, Department of Gynaecological Oncology, Sydney, New South Wales, Australia
  9. 9Medizin Campus Bodensee, Institute of Pathology, Friedrichshafen, Germany
  10. 10Medizin Campus Bodensee, Department of Gynecology and Obstetrics, Friedrichshafen, Germany
  11. 11Kliniken Essen Mitte, Department of Gynecology and Gynecologic Oncology, Essen, Germany
  12. 12University Hospital Tübingen, Institute of Pathology and Neuropathology, Tübingen, Germany
  13. 13University Hospital Heidelberg, Institute of Pathology, Heidelberg, Germany
  14. 14University Hospital Heidelberg and National Center for Tumor Diseases, Department of Obstetrics and Gynecology, Heidelberg, Germany
  15. 15Barts Health National Health Service Trust, Department of Pathology, London, UK
  16. 16University of Pittsburgh School of Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, PA, USA
  17. 17University of Pittsburgh School of Medicine, Department of Pathology, PA, USA
  18. 18Roswell Park Cancer Institute, Department of Cancer Prevention and Control, Buffalo, NY, USA
  19. 19Westmead Hospital, Tissue Pathology and Diagnostic Oncology, Sydney, New South Wales, Australia
  20. 20University of Sydney, Sydney, New South Wales, Australia
  21. 21Western Sydney University, Sydney, New South Wales, Australia
  22. 22Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, New South Wales, Australia
  23. 23The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia
  24. 24German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany
  25. 25Pomeranian Medical University, Department of Genetics and Pathology, International Hereditary Cancer Centre, Szczecin, Poland
  26. 26Pomeranian Medical University, Department of Propaedeutics, Physical Diagnostics and Dental Physiotherapy, Szczecin, Poland
  27. 27The Institute of Cancer Research, Division of Genetics and Epidemiology, London, UK
  28. 28Imperial College London, Department of Metabolism, Digestion and Reproduction, Hammersmith Hospital, London, UK
  29. 29The Institute of Cancer Research, Division of Breast Cancer Research, London, UK
  30. 30The University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, Australia
  31. 31Peter MacCallum Cancer Centre, Women’s Cancer Program, Melbourne, Australia
  32. 32Peter MacCallum Cancer Centre, Cancer Genetics Laboratory, Research Division, Melbourne, Australia
  33. 33The University of New Mexico, Division of Epidemiology and Biostatistics, Albuquerque, NM, USA
  34. 34Cedars-Sinai Medical Center, Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Los Angeles, CA, USA
  35. 35John A. Burns School of Medicine, University of Hawaii, Honolulu, Department of Obstetrics and Gynecology, HI, USA
  36. 36University of Hawaii Cancer Center, Epidemiology Program, Honolulu, HI, USA
  37. 37Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Los Angeles, CA, USA
  38. 38Sahlgrenska Academy at Gothenburg University, Sahlgrenska Center for Cancer Research, Department of Obstetrics and Gynecology, Gothenburg, Sweden
  39. 39Medical University of South Carolina, Hollings Cancer Center and Department of Public Health Sciences, Charleston, SC, USA
  40. 40University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK
  41. 41University College London, Department of Women’s Cancer, Institute for Women’s Health, London, UK
  42. 42University of Innsbruck, EUTOPS Institute, Innsbruck, Austria
  43. 43Washington University School of Medicine, Department of Hematology and Oncology, Division of Oncology, St. Louis, MO, USA
  44. 44University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK
  45. 45Addenbrookes Hospital, Department of Histopathology, Cambridge, UK
  46. 46University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK
  47. 47University of Cambridge, Cancer Research UK Cambridge Institute, Cambridge, UK
  48. 48Fred Hutchinson Cancer Research Center, Program in Epidemiology, Division of Public Health Sciences, Seattle, WA, USA
  49. 49University of Utah, Huntsman Cancer Institute, Department of Population Health Sciences, Salt Lake City, UT, USA
  50. 50University of Calgary, Department of Oncology, Division of Gynecologic Oncology, Calgary, AB, Canada
  51. 51University of British Columbia, Department of Medicine, Vancouver, BC, Canada
  52. 52University of Alberta, Department of Laboratory Medicine and Pathology, Edmonton, AB, Canada
  53. 53Mayo Clinic, Department of Health Science Research, Division of Epidemiology, Rochester, MN, USA
  54. 54Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, BC, Canada
  1. ↵□Co-corresponding authors: Michael S. Anglesio, Department of Obstetrics and Gynecology, University of British Columbia, 2660 Oak Street, Vancouver, BC, Canada. E-mail: m.anglesio{at}ubc.ca. Phone: 604-875-4111, Martin Köbel, Department of Pathology and Laboratory Medicine, University of Calgary, AB, Canada. E-mail: mkoebel{at}ucalgary.ca

  1. ↵* These authors contributed equally to this work.

Back to top
Posted September 21, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma
Karolin Heinze, Tayyebeh M. Nazeran, Sandra Lee, Pauline Krämer, Evan S. Cairns, Derek S. Chiu, Samuel C.Y. Leung, Eun Young Kang, Nicola S. Meagher, Catherine J. Kennedy, Jessica Boros, Friedrich Kommoss, Hans-Walter Vollert, Florian Heitze, Andreas du Bois, Philipp Harter, Marcel Grube, Bernhard Kraemer, Annette Staebler, Felix K.F. Kommoss, Sabine Heublein, Hans-Peter Sinn, Naveena Singh, Angela Laslavic, Esther Elishaev, Alex Olawaiye, Kirsten Moysich, Francesmary Modugno, Raghwa Sharma, Alison H. Brand, Paul R. Harnett, Anna DeFazio, Renée T. Fortner, Jan Lubinski, Marcin Lener, Aleksandra Tołoczko-Grabarek, Cezary Cybulski, Helena Gronwald, Jacek Gronwald, Penny Coulson, Mona A El-Bahrawy, Michael E. Jones, Minouk J. Schoemaker, Anthony J. Swerdlow, Kylie L. Gorringe, Ian Campbell, Linda Cook, Simon A. Gayther, Michael E. Carney, Yurii B. Shvetsov, Brenda Y. Hernandez, Lynne R. Wilkens, Marc T. Goodman, Constantina Mateoiu, Anna Linder, Karin Sundfeldt, Linda E. Kelemen, Aleksandra Gentry-Maharaj, Martin Widschwendter, Usha Menon, Kelly L. Bolton, Jennifer Alsop, Mitul Shah, Mercedes Jimenez-Linan, Paul D.P. Pharoah, James D. Brenton, Kara L. Cushing-Haugen, Holly R. Harris, Jennifer A. Doherty, Blake Gilks, Prafull Ghatage, David G. Huntsman, Gregg S. Nelson, Anna V. Tinker, Cheng-Han Lee, Ellen L. Goode, Brad H. Nelson, Susan J. Ramus, Stefan Kommoss, Aline Talhouk, Martin Köbel, Michael S. Anglesio
medRxiv 2021.09.16.21262993; doi: https://doi.org/10.1101/2021.09.16.21262993
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area